Second-line dovitinib in metastatic endometrial cancer

Matthew S. Block; Sean C. Dowdy

doi:10.1016/S1470-2045(15)70190-7

Second-line dovitinib in metastatic endometrial cancer

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	604-606
Number of pages	3
Journal	The Lancet Oncology
Volume	16
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(15)70190-7
State	Published - Jun 1 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(15)70190-7

Cite this

@article{2e7e4608a06d4cea914d7f637fb78979,

title = "Second-line dovitinib in metastatic endometrial cancer",

author = "Block, {Matthew S.} and Dowdy, {Sean C.}",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/S1470-2045(15)70190-7",

language = "English (US)",

volume = "16",

pages = "604--606",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - Second-line dovitinib in metastatic endometrial cancer

AU - Block, Matthew S.

AU - Dowdy, Sean C.

PY - 2015/6/1

Y1 - 2015/6/1

UR - http://www.scopus.com/inward/record.url?scp=84930277749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930277749&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)70190-7

DO - 10.1016/S1470-2045(15)70190-7

M3 - Comment/debate

C2 - 25981815

AN - SCOPUS:84930277749

SN - 1470-2045

VL - 16

SP - 604

EP - 606

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -

Second-line dovitinib in metastatic endometrial cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this